KRISTIN STRINGER: Open Payments
NPI 1679001259 · GLENDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,932 in 87 payments from 25 companies in 2025. Trend: 2023 $1,884 · 2024 $2,041 · 2025 $1,932
Food & beverage: $1,932
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $309 |
| ABBVIE INC. | 13 | $254 |
| Astellas Pharma US Inc | 7 | $190 |
| Amgen Inc. | 11 | $158 |
| Edwards Lifesciences Corporation | 1 | $143 |
| AstraZeneca Pharmaceuticals LP | 5 | $139 |
| Radius Health, Inc. | 6 | $129 |
| PFIZER INC. | 5 | $97 |
| RECORDATI_RARE_DISEASES_INC. | 3 | $69 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
Products named: Veozah, Wegovy, SAPIEN 3 Ultra RESILIA, Tymlos, BREZTRI, Ozempic, EVENITY, VRAYLAR.
Industry payments across AZ — which companies pay providers there.
